LUNDBECK
LIVE

Serial Number

99163727

Owner

H. Lundbeck A/S

Attorney

Maren Perry

Filing Date

Apr 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LUNDBECK Trademark

Serial Number: 99163727 • Registration: 8148820

LUNDBECK is a trademark filed by H. Lundbeck A/S on April 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial). The application is currently registered and active.

Owner Contact Info

H. Lundbeck A/S (398 trademarks)

Ottiliavej 9
DK-2500 Copenhagen-Valby , DK

Entity Type: 03

Trademark Details

Filing Date

April 30, 2025

Registration Date

February 24, 2026

Published for Opposition

January 6, 2026

Goods & Services

Insurance consultation; financial management for businesses; capital investment; financial analysis; financial management; Providing financial sponsorship of a charity event; Financial sponsorship of science research and scientific projects for the public interest; financing services; investment of funds; providing financial information; granting of grants for scientific research projects; financial grant services in the nature of providing grants for scientific research projects; investment of funds for charitable purposes; provision of monetary grants to charitable organizations in the nature of scientific research institutions; charitable fundraising; advice in connection with the above

Sanitary preparations for medical purposes; dietetic preparations adapted for medical purposes; vaccines; pharmaceutical preparations for the prevention and treatment of disorders and diseases of, generated from or affecting the central nervous system; pharmaceutical preparations and substances for the treatment of central nervous system disorders; central nervous system stimulants; pharmaceutical preparations for the diagnosis, prevention and/or treatment of psychiatric, and neurological, neurohormonal, neuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations for diagnostics, prevention and treatment of Alzheimer's disease, depression, psychosis, anxiety, Lennox-Gastaut disease, epilepsy, Dravet Syndrome, Developmental and Epileptic Encephalopathy (DEE), alpha-synucleinopathies, sclerosis, Multiple System Atrophy (MSA), dementia with Lewy bodies, REM sleep behavior syndrome, porphyria, Huntington's disease, insomnia, Parkinson's disease, schizophrenia, bipolar disorder, oncology, pain, migraine, headache, Horton's headache, traumatic brain injury, post-traumatic brain injury, dizziness, seizures, stroke, cognitive impairment, cognitive disorders and diseases, mood swings, falls, movement disorders and movement disorders, tremor, agitation, mania, aggression, autism, melancholia, OCD, Tourette's syndrome, restlessness, akathisia, fatigue, drowsiness, nausea, Cushing's disease, Adrenogenital syndrome (AGS), narcolepsy, PTSD, ADHD, PSP, Thyroid Associated Orbitopathy (TAO), Graves Orbitopathy, Hashimoto's Thyroiditis, alcoholism and dependency of drugs, alcohol, nicotine and caffeine; Diagnostic preparations, chemical substances, reagents and agents for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 6, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 6, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 31, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2025 NWOS
NEW APPLICATION ENTERED
Apr 30, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Apr 30, 2025 MAFR